Gene · 53353
Papers2,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular characterization of gliosarcoma reveals prognostic biomarkers and clinical parallels with glioblastoma. | J Neurooncol | 2025 | 39476147 | PubTator, text mining | PubMed |
| Presence of RB1 or Absence of LRP1B Mutation Predicts Poor Overall Survival in Patients with Gastric Neuroendocrine Carcinoma and Mixed Adenoneuroendocrine Carcinoma. | Cancer Res Treat | 2025 | 39327909 | PubTator, text mining | PubMed |
Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials. | Sci China Life Sci | 2025 | 39276256 | PubTator, text mining | PubMed |
| Unraveling the genetic susceptibility of irritable bowel syndrome: integrative genome-wide analyses in 845 492 individuals: a diagnostic study. | Int J Surg | 2025 | 39166955 | PubTator, text mining | PubMed |
| Targeted Variant Assessments of Human Endogenous Retroviral Regions in Whole Genome Sequencing Data Reveal Retroviral Variants Associated with Papillary Thyroid Cancer. | Microorganisms | 2024 | 39770638 | PubTator, text mining | PubMed |
| A Rare Case of a Malignant Proliferating Trichilemmal Tumor: A Molecular Study Harboring Potential Therapeutic Significance and a Review of Literature. | Dermatopathology (Basel) | 2024 | 39727620 | PubTator, text mining | PubMed |
| Discover Mutational Differences Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma and Search for More Effective Biomarkers for Immunotherapy. | Cancer Manag Res | 2024 | 39678041 | PubTator, text mining | PubMed |
| Correlations between 14-gene RNA-level assay and clinical and molecular features in resectable non-squamous non-small cell lung cancer: a cross-sectional study. | Transl Lung Cancer Res | 2024 | 39670022 | PubTator, text mining | PubMed |
| LRP1B Suppresses Immunotherapy Efficacy in Lung Adenocarcinoma by Preventing Ferroptosis. | Cancer Med | 2024 | 39660409 | PubTator, text mining | PubMed |
| Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target. | Genome Med | 2024 | 39593114 | PubTator, text mining | PubMed |
| Cell-Free DNA in Plasma Reveals Genomic Similarity Between Biliary Tract Inflammatory Lesion and Biliary Tract Cancer. | Phenomics | 2024 | 39583313 | PubTator, text mining | PubMed |
| LRP1B associated with immune cell infiltration influenced the efficacy of immunotherapy in colorectal cancer patients. | Clinics (Sao Paulo) | 2024 | 39532036 | PubTator, text mining | PubMed |
| Predictive biomarkers for immune checkpoint efficacy: is multi-omics breaking the deadlock? | Transl Lung Cancer Res | 2024 | 39507024 | PubTator, text mining | PubMed |
| Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages. | Nat Cancer | 2024 | 39478117 | PubTator, text mining | PubMed |
| Concurrent EGFR mutation and SMARCA4 deficiency in non-small cell lung cancer: A case report and literature review. | Medicine (Baltimore) | 2024 | 39465834 | PubTator, text mining | PubMed |
| Identification of mutations in canine oral mucosal melanomas by exome sequencing and comparison with human melanomas. | Sci Rep | 2024 | 39406779 | PubTator, text mining | PubMed |
| Anlotinib treatment for rapidly progressing pediatric embryonal rhabdomyosarcoma in the maxillary gingiva: a case report. | Diagn Pathol | 2024 | 39379998 | PubTator, text mining | PubMed |
| TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases. | Heliyon | 2024 | 39258211 | PubTator, text mining | PubMed |
| Characterization of driver mutations identifies gene signatures predictive of prognosis and treatment sensitivity in multiple myeloma. | Oncologist | 2024 | 39250742 | PubTator, text mining | PubMed |
| AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy. | Front Immunol | 2024 | 39238637 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53353/papers?page=6